TY - T1 - Artificially Cloaked Viral Nanovaccine for Cancer Immunotherapy SN - / UR - http://hdl.handle.net/10138/309223 T3 - A1 - Fusciello, Manlio; Fontana, Flavia; Tähtinen, Siri; Capasso, Cristian; Feola, Sara; da Silva Lopes Martins, Beatriz; Chiaro, Jacopo; Peltonen, Karita; Ylösmäki, Leena; Ylösmäki, Erkko; Hamdan Hissaoui, Firas; Kari, Otto K.; Ndika, Joseph; Alenius, Harri; Urtti, Arto; Hirvonen, Jouni T.; Santos, Hélder A.; Cerullo, Vincenzo A2 - PB - Y1 - 2019 LA - eng AB - Virus-based cancer vaccines are nowadays considered an interesting approach in the field of cancer immunotherapy, despite the observation that the majority of the immune responses they elicit are against the virus and not against the tumor. In contrast, targeting tumor associated antigens is effective, however the identification of these antigens remains challenging. Here, we describe ExtraCRAd, a multi-vaccination strategy focused on an oncolytic virus artificially wrapped with tumor cancer mem... VO - IS - SP - OP - KW - ADENOVIRUS; ANTIGEN; CO-DELIVERY; GENE-TRANSFER; IN-VIVO; NANOPARTICLES; OVARIAN-CANCER; SOLID TUMORS; T-CELL THERAPY; VACCINATION; immunotherapy; biohybrid nanoparticles; oncolytic vaccines; oncolytic virus; oncoimmunology; 317 Pharmacy; 318 Medical biotechnology N1 - PP - ER -